Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
1 other identifier
interventional
300
1 country
3
Brief Summary
Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jul 2020
Longer than P75 for phase_4
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2019
CompletedFirst Posted
Study publicly available on registry
July 2, 2019
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedSeptember 19, 2024
September 1, 2024
4.4 years
July 1, 2019
September 10, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Disengagement rate
Rate of disengagement from CSC program
Minimum of 6 months
Study Arms (2)
CSC Step-down intervention
OTHERWeb-based telemedicine and a smartphone app, to decrease disengagement likelihood
Usual Care
OTHERUsual care provided by CSC center
Interventions
Web-based telemedicine and a smartphone app, to decrease disengagement likelihood
Eligibility Criteria
You may qualify if:
- Enrolled into a CSC program
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (3)
Henderson Behavioral Health
Lauderdale Lakes, Florida, 33319, United States
InterAct of Michigan
Grand Rapids, Michigan, 49503, United States
InterAct of Michigan
Kalamazoo, Michigan, 49007, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2019
First Posted
July 2, 2019
Study Start
July 1, 2020
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share